These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 13933581)

  • 1. [Trial treatment by leurocristine of acute lymphoblastic leukemia and of lymphoblastosarcoma].
    MATHE G; SCHWEISGUTH O; BRULE G; BREZIN C; AMIEL JL; SCHWARZENBERG L; SCHNEIDER M; CATTAN A; JASMIN C; SMADJA R
    Presse Med (1893); 1963 Feb; 71():529-32. PubMed ID: 13933581
    [No Abstract]   [Full Text] [Related]  

  • 2. [Trial treatment, by leurocristine, of acute lymphoblastic leukemia and lymphoblastosarcoma].
    MATHE G; SCHWEISGUTH O; BRULE G; BREZIN C; AMIEL JL; SCHWARZENBERG L; SCHNEIDER M; CATTAN A; JASMIN C; SMADJA R
    Nouv Rev Fr Hematol; 1963; 3():478-80. PubMed ID: 13933563
    [No Abstract]   [Full Text] [Related]  

  • 3. [Trial treatment by cyclophosphamide of acute lymphoblastic leukemia and lymphoblastosarcoma].
    MATHE G; SCHWEISGUTH O; BRULE G; SCHNEIDER M; AMIEL JL; SCHWARZENBERG L; CATTAN A
    Presse Med (1893); 1963 Feb; 71():402-4. PubMed ID: 13933580
    [No Abstract]   [Full Text] [Related]  

  • 4. [Trial treatment, by cyclophosphamide. of acute lymphoblastic leukemia and lymphoblastosarcoma].
    MATHE G; SCHWEISGUTH O; BRULE G; SCHNEIDER M; AMIEL JL; SCHWARZENBERG L; CATTAN A
    Nouv Rev Fr Hematol; 1963; 3():480-2. PubMed ID: 13933564
    [No Abstract]   [Full Text] [Related]  

  • 5. Vincristine in the treatment of lymphomas and leukemias.
    BOHANNON RA; MILLER DG; DIAMOND HD
    Cancer Res; 1963 May; 23():613-21. PubMed ID: 13968454
    [No Abstract]   [Full Text] [Related]  

  • 6. [Leurosine, the 3d alkaloid from Vinca rosea, in the treatmen t of Hodgkin's disease, acute lymphoblastic leukemia and lymphoblastosarcoma].
    Schneider M; Band P; Amiel JL; Schwarzenberg L; Cattan A; Schlumberger JR; Mathé G
    Sem Hop; 1966 Nov; 42(49):2952-4. PubMed ID: 4292621
    [No Abstract]   [Full Text] [Related]  

  • 7. [LYMPHOID LEUKEMIA].
    REVOL L
    Rev Prat; 1964 May; 14():1693-711. PubMed ID: 14147344
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of malignancies of the reticuloendothelial system.
    GHRIST TD
    J Iowa State Med Soc; 1963 Feb; 53():72-82. PubMed ID: 13947558
    [No Abstract]   [Full Text] [Related]  

  • 9. CLINICAL EXPERIENCES WITH R 49.
    ECKHARDT S; HARTAI F
    Acta Unio Int Contra Cancrum; 1964; 20():354-6. PubMed ID: 14151927
    [No Abstract]   [Full Text] [Related]  

  • 10. [A CASE OF ACUTE LYMPHOBLASTIC LEUKEMIA INVOLVING EXCEPTIONALLY PROLONGED REMISSIONS].
    MULLER B; FONTANA H; FONTANA J
    Lyon Med; 1965 Mar; 213():873-86. PubMed ID: 14312667
    [No Abstract]   [Full Text] [Related]  

  • 11. LYMPHOSARCOMA CELL LEUKEMIA.
    SCHWARTZ DL; PIERRE RV; SCHEERER PP; REED EC; LINMAN JW
    Am J Med; 1965 May; 38():778-86. PubMed ID: 14286814
    [No Abstract]   [Full Text] [Related]  

  • 12. [ATTEMPT AT TREATMENT OF HODGKIN'S DISEASE AND VARIOUS HEMATOSARCOMAS WITH 1-METHYL-2-P-ALLOPHANOYL-BENZYLHYDRAZINE HYDROBROMIDE].
    MATHE G; SCHNEIDER M; CATTAN A; AMIEL JL; SCHWARZENBERG L; SCHLUMBERGER JR
    Rev Fr Etud Clin Biol; 1964 Nov; 9():990-2. PubMed ID: 14232681
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of combinations of antileukemic agents on an acute lymphocytic leukemia of mice.
    LAW LW
    Cancer Res; 1952 Dec; 12(12):871-8. PubMed ID: 13009674
    [No Abstract]   [Full Text] [Related]  

  • 14. Leurosine sulfate (NSC-90636) in treatment of Hodgkin's disease, acute lymphoblastic leukemia, and lymphoblastic lymphosarcoma.
    Mathe G; Schneider M; Bond P; Amiel JL; Schwarzenberg L; Cattan A; Schlumberger JR
    Cancer Chemother Rep; 1965 Dec; 49():47-9. PubMed ID: 5322839
    [No Abstract]   [Full Text] [Related]  

  • 15. Leukemia and lymphoma.
    White LP
    Geriatrics; 1970 Dec; 25(12):82-6. PubMed ID: 5274229
    [No Abstract]   [Full Text] [Related]  

  • 16. [RESULTS OF CLINICAL TESTS OF A NEW CYTOSTATIC SUBSTANCE FROM THE METHYLHYDRAZINE SERIES (NATULAN)].
    BEGEMANN H; BLUM KU; FELLMER KE; FOELSCH E; GERHARTZ H; GRUNZE H; HAUSMANN K; HENNES R; JUENGLING W; KLEIBEL F; KOERTGE P; MARING H; MARTIN H; OBRECHT P; OSTEN W; PABST HW; POLIWODA H; SCHUBERT JC; SEIDL S; SPECHTER HJ; STRICKSTROCK KH; WITTE S; DREWS J
    Med Klin; 1965 Jun; 60():960-4. PubMed ID: 14304965
    [No Abstract]   [Full Text] [Related]  

  • 17. 5 YEARS EXPERIENCE WITH DIFFERENT N-LOST-PHOSPHAMIDESTERS IN TUMOR CHEMOTHERAPY.
    GROSS R
    Acta Unio Int Contra Cancrum; 1964; 20():369-72. PubMed ID: 14151932
    [No Abstract]   [Full Text] [Related]  

  • 18. [Transitory lymphoblastic episodes observed during the treatment of chronic and subacute malignant lymphoid hemopathies with large doses of delta-cortisone].
    BOIRON M; BRULE G; LEVY JP
    Nouv Rev Fr Hematol; 1962; 2():370-7. PubMed ID: 13968525
    [No Abstract]   [Full Text] [Related]  

  • 19. [Relation of lymphoid leukemia to lymphosarcoma].
    KELLNER B
    Magy Onkol; 1961 Dec; 5():22-33. PubMed ID: 14454990
    [No Abstract]   [Full Text] [Related]  

  • 20. The clinical implications of hypogammaglobul inemia in patients with chronic lymphocytic leukemia and lymphocytic lymphosarcoma.
    ULTMANN JE; FISH W; OSSERMAN E; GELLHORN A
    Ann Intern Med; 1959 Sep; 51():501-16. PubMed ID: 13840332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.